Relationship of serum transforming growth factor-β,matrix metalloproteinases-1 and tissue inhibitors of metalloproteinase-1 with the severity of liver fibrosis
Long Bo
Abstract
Long Bo
Abstract
Objective:To investigate the relationship of serum transforming growth factor-β,matrix metalloproteinases-1 and tissue inhibitors of metalloproteinase-1 with the severity of liver fibrosis.Methods:A total of 80 patients with HBV related liver fibrosis and early fibrosis were enrolled from one hospital.Serum fibrosis markers including hyaluronic acid(HA),IV collagen(IV-C),aminoterminal propeptide of type Ⅲ procollagen(PⅢP),laminin(LN),matrix metalloproteinases-1(MMP-1)and tissue inhibitors of metalloproteinase-1(TIMP)-1 and transforming growth factor-β(TGF-β) Levels were determined.liver fibrosis were assessed according to a modified Scheuer and Chevallier'sscoring system.Results:In the patients of different stages of liver fibrosis,serum TGF-β,TIMP-1 and TIMP-1/MMP-1 were different(P0.01) and serum MMP-1 was not remarkably different.Serum TGF-β(r=0.745,P0.01),TIMP-l(r=0.623,P0.01) and TIMP-1/MMP-l(r=0.336,P0.01) were correlated positively with the degree of hepatic fibrosis,whereas serum MMP-1(r=-0.465,P0.01) was correlated negatively.In The patients without remarkably increasing hepatic fibrosis degree,serum TGF-β,TIMP-1/MMP-1 and TIMP-1 were lower and had not increased.Conclusion:Serum TGF-β,TIMP-1 and TIMP-1/MMP-1 can be used as indices of evaluating hepatic fibrosis degree and growth.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the relationship of serum transforming growth factor-β,matrix metalloproteinases-1 and tissue inhibitors of metalloproteinase-1 with the severity of liver fibrosis.Methods:A total of 80 patients with HBV related liver fibrosis and early fibrosis were enrolled from one hospital.Serum fibrosis markers including hyaluronic acid(HA),IV collagen(IV-C),aminoterminal propeptide of type Ⅲ procollagen(PⅢP),laminin(LN),matrix metalloproteinases-1(MMP-1)and tissue inhibitors of metalloproteinase-1(TIMP)-1 and transforming growth factor-β(TGF-β) Levels were determined.liver fibrosis were assessed according to a modified Scheuer and Chevallier'sscoring system.Results:In the patients of different stages of liver fibrosis,serum TGF-β,TIMP-1 and TIMP-1/MMP-1 were different(P0.01) and serum MMP-1 was not remarkably different.Serum TGF-β(r=0.745,P0.01),TIMP-l(r=0.623,P0.01) and TIMP-1/MMP-l(r=0.336,P0.01) were correlated positively with the degree of hepatic fibrosis,whereas serum MMP-1(r=-0.465,P0.01) was correlated negatively.In The patients without remarkably increasing hepatic fibrosis degree,serum TGF-β,TIMP-1/MMP-1 and TIMP-1 were lower and had not increased.Conclusion:Serum TGF-β,TIMP-1 and TIMP-1/MMP-1 can be used as indices of evaluating hepatic fibrosis degree and growth.
Key concepts: Medicine, Matrix metalloproteinase, Fibrosis, Procollagen peptidase, Transforming growth factor, Internal medicine, Metalloproteinase, Hepatic fibrosis